β-Carboline and chloroquine hybrids as potent antiplasmodial agents: Design, synthesis and biological evaluation
References
- S. Kumar, T. R. Bhardwaj, D. N. Prasad and R. K. Singh, Drug targets for resistant malaria: Historic to future perspectives, Biomed. Pharmacother. 104 (2018) 8–27; https://doi.org/10.1016/j.biopha.2018.05.009
- J. L. Siqueira-Neto, K. J. Wicht, K. Chibale, J. N. Burrows, D. A. Fidock and E. A. Winzeler, Anti-malarial drug discovery: Progress and approaches, Nat. Rev. Drug Discov. 22(10) (2023) 807–826; https://doi.org/10.1038/s41573-023-00772-9
- World Health Organization. World malaria report 2025. Geneva: World Health Organization; 2025; https://www.who.int/publications/i/item/world-malaria-report-2025; last access date March 15, 2026.
- MMV’s pipeline of antimalarial drugs; https://www.mmv.org/mmv-pipeline-antimalarial-drugs; last access date March 15, 2026
- H. Li, S. Ji, N. R. Ariefta, E. M. S. Galon, S. A. E. S. El-Sayed, T. Do, L. Jia, M. Sakaguchi, M. Asada, Y. Nishikawa, X. Qin, M. Liu and X. Xuan, Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate, eLife 13 (2025) Article ID RP101128 (17 pages); https://doi.org/10.7554/eLife.101128
- D. G. Okwu, R. Z. Manego, S. Duparc, P. G. Kremsner, M. Ramharter and G. Mombo-Ngoma, The non-artemisinin antimalarial drugs under development: A review, Clin. Microbiol. Infect. 31(6) (2025) 941–947; https://doi.org/10.1016/j.cmi.2025.03.009
- B. K. S. Yeung, KAE609 (Cipargamin): Discovery of spiroindolone antimalarials, Novartis Institute for Tropical Diseases, Singapore.
- M. Lenharo, First new type of malaria treatment in decades shows promise against drug resistance, Nature 647(8091) (2025) Article ID 830 (1 page); https://doi.org/10.1038/d41586-025-03690-5
- G. M. LaMonte, F. Rocamora, D. S. Marapana, N. F. Gnädig, S. Ottilie, M. R. Luth, T. S. Worgall, G. M. Goldgof, R. Mohunlal, T. R. Santha Kumar, J. K. Thompson, E. Vigil, J. Yang, D. Hutson, T. Johnson, J. Huang, R. M. Williams, B. Y. Zou, A. L. Cheung, P. Kumar, T. J. Egan, M. C. S. Lee, D. Siegel, A. F. Cowman, D. A. Fidock and E. A. Winzeler, Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway, Nat. Commun. 11(1) (2020) Article ID 1780 (15 pages); https://doi.org/10.1038/s41467-020-15440-4
- T. Umumararungu, J. B. Nkuranga, G. Habarurema, J. B. Nyandwi, M. J. Mukazayire, J. Mukiza, R. Muganga, I. Hahirwa, M. Mpenda, A. N. Katembezi, E. O. Olawode, E. Kayitare and P. C. Kayumba, Recent developments in antimalarial drug discovery, Bioorg. Med. Chem. 88–89 (2023) Article ID 117339 (21 pages); https://doi.org/10.1016/j.bmc.2023.117339
- S. Tahlan, S. Singh, M. Kaira, H. Dey and K. C. Pandey, A progress report in advancements of heterocyclic compounds as novel antimalarial agents over the last 5 years, Eur. J. Med. Chem. 289 (2025) Article ID 117393 (53 pages); https://doi.org/10.1016/j.ejmech.2025.117393
- N. J. White, Tafenoquine – a new antimalarial drug, Clin. Infect. Dis. 69(10) (2019) 1816–1823; https://doi.org/10.1093/cid/ciz070
- B. Meunier and A. Robert, Heme as a target for antimalarial drugs, Acc. Chem. Res. 43(1) (2010) 144–150; https://doi.org/10.1021/ar900207e
- V. Vaishali, V. Kumar, D. Singh, S. Sharma and V. Singh, A deep insight into synthetic and medicinal potential of β-carboline derivatives: An update, ChemistrySelect 10 (2025) e02142 (60 pages); https://doi.org/10.1002/slct.202502142
- J. Haldar, Combination therapy: A pillar in the fight against infectious diseases, ACS Infect. Dis. 11(12) (2025) 3379–3385; https://doi.org/10.1021/acsinfecdis.5c00932
- M. L. Stofberg, C. Caillet, M. de Villiers and T. Zininga, Inhibitors of the Plasmodium falciparum Hsp90 towards selective antimalarial drug design: the past, present and future, Cells 10(11) (2021) Article ID 2849 (30 pages); https://doi.org/10.3390/cells10112849
- A. Penava, M. Marinović, L. P. de Carvalho, J. Held, I. Piantanida, D. P. Saftić, Z. Rajić and I. Perković, Towards novel antiplasmodial agents – design, synthesis and antimalarial activity of second-generation β-carboline/chloroquine hybrids, Molecules 29(24) (2024) Article ID 5991 (30 pages); https://doi.org/10.3390/molecules29245991
- B. Bálint, C. Wéber, F. Cruzalegui, M. Burbridge and A. Kotschy, Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition, ChemMedChem 12(12) (2017) 932–939; https://doi.org/10.1002/cmdc.201600539
- S. Eagon and M. O. Anderson, Microwave-assisted synthesis of tetrahydro-β-carbolines and β-carbolines, Eur. J. Org. Chem. 2014 (2014) 1653–1665; https://doi.org/10.1002/ejoc.201301580
- G. Poje, L. P. Pessanha de Carvalho, J. Held, D. Moita, M. Prudêncio, I. Perković, T. Tandarić, R. Vianello and Z. Rajić, Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents, Eur. J. Med. Chem. 238 (2022) Article ID 114408 (15 pages); https://doi.org/10.1016/j.ejmech.2022.114408
- Website for prediction of physicochemical descriptors, ADME parameters, pharmacokinetic properties, druglike nature and medicinal chemistry friendliness of one or multiple small molecules, SwissADME; http://www.swissadme.ch; last access date March 15 2026.
- L. P. de Carvalho, S. Groeger-Otero, A. Kreidenweiss, P. G. Kremsner, B. Mordmüller and J. Held, Boromycin has rapid-onset antibiotic activity against asexual and sexual blood stages of Plasmodium falciparum, Front. Cell. Infect. Microbiol. 11(1) (2022) Article ID 802294 (13 pages); https://doi.org/10.3389/fcimb.2021.802294
- H. Noedl, J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch and M. Fukuda, Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing, Antimicrob. Agents Chemother. 49(9) (2005) 3575–3577; https://doi.org/10.1128/AAC.49.8.3575-3577.2005
- R Core Team. A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021; https://www.r-project.org/; last access date December 21 2021.
- E. Borenfreund and J. A. Puerner, A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90), J. Tissue Cult. Methods 9 (1985) 7–9; https://doi.org/10.1007/BF01666038
- M. V. de Souza, K. C. Pais, C. R. Kaiser, M. A. Peralta, M. de Ferreira and M. C. Lourenço, Synthesis and in vitro antitubercular activity of a series of quinoline derivatives, Bioorg. Med. Chem. 17 (2009) 1474–1480; https://doi.org/10.1016/j.bmc.2009.01.013
- M. Kitamura, T. Koga, M. Yano and T. Okauchi, Direct synthesis of organic azides from alcohols using 2-azido-1,3-dimethyl-imidazolinium hexafluorophosphate, Synlett. 23 (2012) 1335–1338; https://doi.org/10.1055/s-0031-1290958
- K. Starčević, D. Pešić, A. Toplak, G. Landek, S. Alihodžić, E. Herreros, S. Ferrer, R. Spaventi and M. Perić, Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents, Eur. J. Med. Chem. 49 (2012) 365–378; https://doi.org/10.1016/j.ejmech.2012.01.039.
- R. Frederick, C. Bruyere, C. Vancraeynest, J. Reniers, C. Meinguet, L. Pochet, A. Backlund, B. Masereel, R. Kiss and J. Wouters, Novel trisubstituted harmine derivatives with original in vitro anticancer activity, J. Med. Chem. 55 (2012) 6489−6501; https://doi.org/10.1021/jm300542e
- M. Marinović, G. Poje, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. P. de Carvalho, T. Tandarić, R. Vianello and Z. Rajić, Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action, Eur. J. Med. Chem. 224 (2021) Article ID 113687 (20 pages); https://doi.org/10.1016/j.ejmech.2021.113687
- X. Y. Huo, L. Guo, X. F. Chen, Y. T. Zhou, J. Zhang, X. Q. Han and B. Dai, Design, synthesis, and antifungal activity of novel aryl-1,2,3-triazole-β-carboline hybrids, Molecules 23(6) (2018) Article ID 1344 (11 pages); https://doi.org/10.3390/molecules23061344
- R. Otto, R. Penzis, F. Gaube, T. Winckler, D. Appenroth, C. Fleck, C. Tränkle, J. Lehmann and C. Enzensperger, Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison, Eur. J Med. Chem. 87 (2014) 63–70; https://doi.org/10.1016/j.ejmech.2014.09.048
- L.-L. Yang, Y.-Y. He, Q.-L. Chen, S. Qian and Z.-Y. Wang, Design and synthesis of new 9-substituted norharmane derivatives as potential Sirt5 inhibitors, J. Heterocyclic Chem. 54 (2017) 1457–1466; https://doi.org/10.1002/jhet.2732
- A. Daina, O. Michielin and V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017) Article ID 42717 (13 pages); https://doi.org/10.1038/srep42717
Language: English
Page range: 1 - 26
Accepted on: May 14, 2026
Published on: Jun 30, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Ana Penava, Lais Pessanha De Carvalho, Jana Held, Goran Poje, Zrinka Rajić, Ivana Perković, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.